Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $103,599,594.95
- Sept. 16, 2024
- Alec Machiels
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 15, 2022 | N/A | 1,250 | $46.33 | Sell | $57,912.50 | |
July 8, 2022 | Chief Scientific Officer | 12,000 | $47.95 | Sell | $575,400.00 | |
June 27, 2022 | Director | 1,341 | $46.79 | Sell | $62,745.39 | |
June 23, 2022 | Director | 15,000 | $45.00 | Sell | $675,000.00 | |
June 22, 2022 | General Counsel | 10,000 | $44.51 | Sell | $445,100.00 | |
June 17, 2022 | Insider | 2,698 | $45.00 | Sell | $121,410.00 | |
June 16, 2022 | SVP | 10,000 | $41.78 | Sell | $417,800.00 | |
June 15, 2022 | Director | 1,250 | $39.29 | Sell | $49,112.50 | |
June 1, 2022 | Insider | 2,500 | $41.78 | Sell | $104,450.00 | |
May 27, 2022 | Insider | 10,000 | $43.00 | Sell | $430,000.00 | |
May 16, 2022 | Director | 1,250 | $39.18 | Sell | $48,975.00 | |
May 2, 2022 | Insider | 2,500 | $43.56 | Sell | $108,900.00 | |
April 29, 2022 | Insider | 4,000 | $44.43 | Sell | $177,720.00 | |
April 25, 2022 | General Counsel | 5,000 | $50.00 | Sell | $250,000.00 | |
April 20, 2022 | SVP | 7,000 | $52.53 | Sell | $367,710.00 | |
April 14, 2022 | Director | 1,250 | $50.90 | Sell | $63,625.00 | |
April 4, 2022 | Insider | 3,504 | $56.96 | Sell | $199,587.84 | |
April 1, 2022 | Insider | 11,496 | $55.05 | Sell | $632,854.80 | |
March 15, 2022 | Director | 1,250 | $39.57 | Sell | $49,462.50 | |
March 15, 2022 | Insider | 375 | $39.57 | Sell | $14,838.75 | |
Feb. 15, 2022 | Director | 1,250 | $45.43 | Sell | $56,787.50 | |
Feb. 15, 2022 | Insider | 375 | $45.43 | Sell | $17,036.25 | |
Feb. 11, 2022 | Insider | 1,666 | $46.80 | Sell | $77,968.80 | |
Feb. 8, 2022 | Insider | 10,000 | $45.00 | Sell | $450,000.00 | |
Jan. 31, 2022 | Insider | 1,233 | $38.47 | Sell | $47,433.51 | |
Jan. 14, 2022 | Director | 1,250 | $40.56 | Sell | $50,700.00 | |
Jan. 14, 2022 | Insider | 375 | $40.56 | Sell | $15,210.00 | |
Dec. 27, 2021 | General Counsel | 1,200 | $48.50 | Sell | $58,200.00 | |
Dec. 22, 2021 | General Counsel | 10,571 | $47.81 | Sell | $505,399.51 | |
Nov. 18, 2021 | Major Shareholder | 250,000 | $40.00 | Buy | $10,000,000.00 | |
Nov. 1, 2021 | Insider | 625 | $30.70 | Sell | $19,187.50 | |
Oct. 14, 2021 | Insider | 750 | $34.57 | Sell | $25,927.50 | |
July 21, 2021 | SVP | 1,000 | $65.00 | Sell | $65,000.00 | |
July 15, 2021 | Director | 2,500 | $62.30 | Sell | $155,750.00 | |
July 15, 2021 | SVP | 1,000 | $62.30 | Sell | $62,300.00 | |
July 14, 2021 | Insider | 500 | $64.68 | Sell | $32,340.00 | |
July 8, 2021 | Insider | 250 | $65.68 | Sell | $16,420.00 | |
June 24, 2021 | Insider | 6,250 | $65.61 | Sell | $410,062.50 | |
June 15, 2021 | Director | 2,500 | $64.83 | Sell | $162,075.00 | |
June 15, 2021 | SVP | 4,000 | $64.96 | Sell | $259,840.00 | |
June 14, 2021 | Insider | 500 | $61.84 | Sell | $30,920.00 | |
June 11, 2021 | VP | 1,000 | $61.55 | Sell | $61,550.00 | |
June 10, 2021 | Insider | 3,417 | $60.00 | Sell | $205,020.00 | |
June 1, 2021 | VP | 1,000 | $56.40 | Sell | $56,400.00 | |
May 20, 2021 | Director | 5,773 | $48.10 | Sell | $277,681.30 | |
May 18, 2021 | SVP | 2,000 | $55.00 | Sell | $110,000.00 | |
May 18, 2021 | Director | 149,488 | $52.85 | Sell | $7,900,440.80 | |
April 30, 2021 | VP | 1,000 | $50.00 | Sell | $50,000.00 | |
April 23, 2021 | Insider | 6,250 | $46.13 | Sell | $288,312.50 | |
April 21, 2021 | Director | 2,500 | $45.76 | Sell | $114,400.00 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Federico Grossi, Cedric Francois, Pascal Deschatelets, A. Sinclair Dunlop, Mark Jeffrey Delong, David O Watson, Adam J Townsend, Lukas Scheibler, Timothy Eugene Sullivan, Nicole D Perry, James George Chopas, Jeffrey Eisele, Morningside Venture Investment, Karen Lewis, Nur Nicholson, Global Strategic Fund I Venbio, Victoria L. Brown, Deschatelets Pascal, Caroline Baumal, Victoria L Brown, and Machiels Alec
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $50,716,137.07.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Sept. 16, 2024.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.